Ballota: benefits, dosage, contraindications
Other name(s)
Black horehound
Scientific name(s)
Ballota nigra
Family or group:
Plants
Active ingredients:
Verbascoside
Indications
Rating methodology
EFSA approval.
Nervousness, Sleep disorders ✪✪✪✪✪
In an open clinical study, 28 patients suffering from generalized anxiety disorders, in accordance with the Diagnostic and Statistical Manual of Mental Disorders (DSM III-R), including depression and sleep disorders, were treated daily for 90 days with 3 doses of 5 ml of a liquid Ballota nigra preparation, corresponding to 3 x 0.5 g of plant. Response rates after 60 and 90 days were 65% and 73% respectively. Patients with sleep disorders showed particularly notable improvement. Out of 10 patients using benzodiazepines prior to the study, 3 stopped their treatment and 4 reduced their dose by half. Ballota nigra is recognized for its effectiveness in treating mild nervous states, insomnia, and accompanying anxious-depressive states. ESCOP confirms these indications, specifying that Ballota nigra helps relieve tension, agitation, and irritability, with difficulties in falling asleep.
Posologie
Properties
Sedative
The sedative effect of Ballota could be attributed to phenylpropanoid glycosides such as verbascoside and forsythoside B, which interact with benzodiazepine and dopaminergic receptors, mimicking the action of neuroleptics. These compounds could also reduce locomotor activity and slow down electroencephalographic activity due to their powerful antioxidant action. Studies indicate that these phenylpropanoids, by neutralizing free radicals and reducing oxidants, contribute to neuroprotection and the sedative effect, thus offering therapeutic potential against stress and nervous disorders.
Usages associés
Antibacterial
Ballota exhibits antimicrobial activity, acting against various pathogens such as Escherichia coli, Staphylococcus aureus, and Salmonella typhi. Extracts from different parts of the plant, notably the root, stem, and leaves, have demonstrated significant efficacy.
Safety dosage
Adult from 12 years old:
- infusion: 1.5-4 g per infusion, 3 times a day. - fluid extract: 1-3 mL (1:1, alcoholic at 25%), 3 times a day. - tincture: 1-2 mL (1:10 alcoholic at 45%), 3 times a day.
Child from 3 to 12 years old:
The use of Ballota in children aged 3 to 12 years should only be carried out under medical supervision. The recommended dosage for children is proportional to the adult dose based on their body weight. It is preferable to use non-alcoholic preparations to administer Ballota to children.
Interactions
Médicaments
Dopamine agonist: moderate interaction
The interaction between Ballota and dopaminergic agonists may have theoretical additive effects. Certain substances present in Ballota bind to dopaminergic D2 receptors in vitro, but this has not yet been reported in humans. Dopaminergic agonists include bromocriptine (Parlodel), levodopa (Dopar, component of Sinemet), pramipexole (Mirapex), ropinirole (Requip), among others.
Precautions
Pregnant woman: avoid
Ballota is supposed to have an effect on the menstrual cycle, although this has not been scientifically demonstrated. Therefore, its use is contraindicated during pregnancy and breastfeeding.
Breastfeeding woman: avoid
Ballota is supposed to have an effect on the menstrual cycle, although this has not been scientifically demonstrated. Therefore, its use is contraindicated during pregnancy and breastfeeding.